2019 ASCCP Risk-Based Management Consensus Guidelines Committee. J Low Genit Tract Dis 2020;24:10231. cervical cancer screening have come out since 2012, such as primary HPV as a screening option for patients 25 years clinical study, scientific report, draft regulation) is released that requires an immediate or rapid response, particularly if it is anticipated that it will generate a multitude of inquiries. 2022 Dec 13;3(1):130. doi: 10.1186/s43058-022-00382-3. Management of results during post colposcopy surveillance (within past 7 years): Management of current HPV and/or cytology results for patients who previously were triaged to 1-year, 3-year or 5-year follow-up after colposcopy. Although many of the management recommendations remain unchanged from the 2012 guidelines, there are several important updates (Box 1). cervical cancer screening tests and cancer precursors. Within this text, HPV refers specifically to high-risk HPV as 3. Updated guidelines published in October 2007 place greater emphasis on testing for high-risk human papillomavirus (HPV). This evaluation may include cervical cytology, colposcopy, diagnostic imaging, and cervical, endocervical, or endometrial biopsy. <>
A Pap test, also called a Pap smear or cervical cytology, is a way of screening for cervical cancer. your express consent. 2f8
Hf8*@r9MXNw6JXbc```3=20(.bbc`Sb0 Z
2) Enter the patient's age and the clinical situation. hbbd``b`Z$EA/@H+/H@O@Y> t(
This Practice Advisory was developed by the American College of Obstetricians and Gynecologists in collaboration with David Chelmow, MD. Chan School of Public Health, Boston, MA, 9University of California, Los Angeles, CA, 10Northwestern University, Feinberg School of Medicine-Northwestern Memorial Hospital, Chicago, IL, 11Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, 12University of California, San Francisco, San Francisco, California, 13Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, 14Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, Bethesda, MD. The guidelines effort received support from ASCCP and the National Cancer Institute. PMC time. -. 132 0 obj
<>stream
J Low Genit Tract Dis. The ASCCP Risk-Based Management Consensus Guidelines represent a consensus of nearly 20 professional organizations Careers. only to patients without risk factors. Similarly, if a patient had a high-grade cytology result, including atypical squamous cells cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) atypical glandular cells, (AGC) or high grade squamous intraepithelial lesion (HSIL), and did not receive a colposcopy, colposcopy is recommended. Egemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, Poitras N, Befano B, Locke A, Guido RS, Wiser AL, Gage JC, Katki HA, Wentzensen N, Castle PE, Schiffman M, Lorey TS. recommendations for the practice of colposcopy. 2020 Jul-Aug;9(4):291-303. doi: 10.1016/j.jasc.2020.05.002. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference.
risk of cervical intraepithelial neoplasia (CIN) grade 3 (CIN3) or more severe diagnoses (CIN3+), regardless of 1. In addition, several new recommendations for J Am Soc Cytopathol. Methods: HSIL Pap cases with hrHPV co-testing were retrospectively reviewed from June 2015 to September 2020 in our archive.
For individuals aged 25 or older screened with cytology alone, the 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors2 are recommended for management of abnormal results. We don't have any prior history in this particular case. The Centers for Disease Control and Prevention reports that 79 million Americans are infected with HPV and an additional 14 million are newly infected each year.3 Data from early HPV vaccine trials suggest that the lifetime prevalence of the infection is 85% in women and 91% in men who have had at least one sex partner.8. HPV vaccination is ideally administered at 11 or 12 years of age and may be administered as early as nine years of age, irrespective of the patient's sex. This was a large consensus effort involving several clinical organizations, federal agencies, and patient representatives. Colposcopic examination confirming CIN1 or less within 1 year. The risk database will continue to be updated as new testing methods and follow-up data emerge, and the new framework will allow management to be adjusted accordingly and consistently. found when histology or cytology is inconclusive such as a result of LSIL cannot rule out HSIL. 17-19 Patients with a history of abnormal test results require more frequent testing as recommended by the ASCCP. 1) In this case, we would enter the data as we did before and continue clicking button until we get to the recommendations page. Available at: ASCCP management guidelines app quick start guide. HPV: this term refers to Human Papillomavirus. Publications tab - This has all the main papers that were used in conjunction with the development of the guidelines. Long-term surveillance after treatment for histologic HSIL (CIN 2 or CIN 3) or AIS involves HPV-based testing at 3-year intervals for 25 years, regardless of whether the patient has had a hysterectomy either for treatment or at any point during the surveillance period (CIII). Note that a negative past history should be entered only when documented in the medical record and performed on This site needs JavaScript to work properly. Journal of Lower Genital Tract Disease25(4):330-331, October 2021. Li Z, Griffith CC, Yan S, Chen C, Ding X, Liang X, Yang H, Zhao C. Prior high-risk HPV testing and Pap test results for 427 invasive cervical . Perkins RB, Guido RS, Castle PE, et al. Management of abnormal cervical cancer screening results should follow current ASCCP guidelines 3 4 . to routine screening. Squamous Intraepithelial Lesion (SIL): A term used to describe abnormal cervical cells detected by the Pap test. screening test and biopsy results, while considering personal factors such as age and immunosuppression. Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus HPV infection is the most common sexually transmitted infection in the United States. %%EOF
Any person with a cervix should be screened, regardless of gender identity, sexual orientation . 2. The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide recommendations for the care of patients with abnormal cervical cancer screening results. %PDF-1.5
%
The new guidelines rely on individualized assessment of risk taking into account past history and current results. Finally, both clinicians and patients need to recognize that while most cases of cervical cancer can be prevented & D@eLiat2D_*0N-!d0.a*#h & 2e Recommendations on New Standards of Colposcopy Practice, - Image Archive- EMR Templates- Patient Resources- Member Directory- Photo Gallery- Clinical Practice Listserv- Cases of the Month- Colposcopy Standards Paper Note- Vulvovaginal Disorders Resource. Bethesda, MD 20894, Web Policies effective and invasive cervical cancer can develop in women participating in such programs. Results: 1405 HSIL Pap cases were identified, including 1071 with six-month histopathological follow-up. patient's risk of progressing to precancer or cancer. The National Cancer Institute (including M.S. The updated management guidelines aim to: Allow for a more complete and precise estimation of risk Provide more appropriate intervention for high-risk individuals (detect and treat more. Consistent with prior guidance, screening should begin at age 21 years, and screening recommendations remain unchanged for average-risk individuals aged 21-29 years and those who are older than 65 years Table 1. A.-B.M. The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide recommendations for the care of patients with abnormal cervical cancer screening results. <>/ExtGState<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 1008 612] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>>
HPV vaccination is not routinely recommended in individuals 27 years or older. Essential Changes From Prior Management Guidelines. may email you for journal alerts and information, but is committed
2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. through a program of screening and management of cervical precancer, no screening or treatment modality is 100% Participating organizations Genital warts occur in 1% of sexually active adults.3 The prevalence of HPV infection peaks in the early 20s in women and in the mid-20s to early 30s in men, based on data from population registries and the National Health and Nutrition Examination Survey.9,10 A second peak occurs in postmenopausal women and older men and may be associated with a combination of new and persistent infection.1012 The average number of annual HPV-related carcinomas in the United States is summarized in eTable A. 4 0 obj
Cytology every three years (liquid or conventional) Recommend against annual Pap smear. A Question to the 2019 ASCCP Risk-Based Management Consensus Guidelines. An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines. stream
J Low Genit Tract Dis 2020;24:10231. follow-up at longer surveillance intervals and, when at sufficiently low risk, return to routine screening. In this case, the patient had an ASCUS pap test result and a positive high risk test results. The corresponding authors had final responsibility for the submission decision. 1017 0 obj
<>
endobj
Federal government websites often end in .gov or .mil. 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. endobj
2019 ASCCP risk-based management consensus guidelines for abnormal HPV testing or cotesting at more frequent intervals than are recommended for screening. Expedited treatment: this term means treatment without confirmatory colposcopic biopsy (e.g., see and Schwameis R, Ganhoer-Schimboeck J, Hadjari VL, Hefler L, Bergmeister B, Kssel T, Gittler G, Steindl-Schoenhuber T, Grimm C. Cancers (Basel). Some error has occurred while processing your request. Publications of the American College of Obstetrician and Gynecologists are protected by copyright and all rights are reserved. Furthermore, since prior test results affect risk, patients with prior abnormalities often require surveillance with *For nonpregnant patients 25 years or older. What should we do to find out the next step for this patient? Nayar R, Chhieng DC, Crothers B, Darragh TM, Davey DD, Eisenhut C, Goulart R, Huang EC, Tabbara SO. The College's publications may not be reproduced in any form or by any means without written permission from the copyright owner. Xiong S, Lazovich A, Hassan F, Ambo N, Ghebre R, Kulasingam S, Mason SM, Pratt RJ. endobj
The ability to adjust to the rapidly emerging science is critical for the Unlike the 2012 ASCCP guidelines that relied on test results-based algorithms, the new consensus guidelines follow a risk-based approach to determine the need for surveillance, colposcopy, or treatment. He has been the overall PI or local PI for clinical trials from Johnson&Johnson, Pfizer, Iovance, and Inovio. marked Pap smear, repeat colposcopy MAY not change management even if negative, so it may be appropriate to proceed with a diagnostic excisional procedure if review of material is not an option. and R.S.G. Unauthorized use of these marks is strictly prohibited. Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. 2012 Jul;16(3):175-204. doi: 10.1097/LGT.0b013e31824ca9d5.
The goals of the ASCCP Risk-Based Management Consensus specimen for histologic analysis, such as Loop Electrosurgical Excision Procedure (LEEP), Large Loop Excision of the An HPV test looks for infection with the types of HPV that are linked to cervical cancer. Table 1. high quality evidence, and in these situations the guidelines have, by necessity, been based on consensus expert If everything is correct, click next and move on to the recommendations page. endstream
endobj
startxref
If for any reason you entered something incorrectly, press the back button to go back and reenter data. Penis: The male sex organ. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Implement Sci Commun. Available at. Expedited treatment was an option for patients with high-grade squamous intraepithelial lesion (HSIL) cytology in the 2012 guidelines; this guidance is now better defined. | Terms and Conditions of Use. The new management guidelines are lengthy and include six supporting papers (see Resources section). 2 0 obj
Copyright 2021 by the American Academy of Family Physicians. management from one that is based on specific test results to one that is based on a patient's risk will allow for The app is only to be used by medical professionals and email addresses will be retained under the terms of the privacy policy. Sometimes cytology or pathology are not conclusive. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Management guidelines FAQs. test (to determine the presence/absence of HPV 16/18), and also a reflex cytology test to determine whether the New for these guidelines, a positive screening HPV test should trigger both a reflex genotyping 1044 0 obj
<>/Filter/FlateDecode/ID[<51FC2DB85E610A4EB791D667E0A1A1A7>]/Index[1017 59]/Info 1016 0 R/Length 110/Prev 455981/Root 1018 0 R/Size 1076/Type/XRef/W[1 3 1]>>stream
The application uses data and recommendations from the following sources: The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). high-risk HPV types only. hb```b``a`O@(E$0v
"b$3A{fn8EXZ3N?v[U}?{P_n\e Read all of the Articles Read the Main Guideline Article Management Guidelines One of the most important updates to the guidelines is the recognition of the importance of previous human papillomavirus (HPV) test results. One study demonstrated that 31% of genital warts contain both low- and high-risk types of HPV.20. Risk Based Management Guidelines Creator: Stella Bebos Updated: 10/12/2021 Contains: 11 items Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors Perkins, Rebecca B.; Guido, Richard S.; Castle, Philip E.; More The 2019 ASCCP Risk-Based Management Consensus Guidelines 1 represent a paradigm shift from using primarily results-based algorithms to using risk-based management based on a combination of current screening test results and past screening history. Immediate, unlimited access to all AFP content, Immediate, unlimited access to this issue's content, Immediate, unlimited access to just this article. The 2012 consensus guidelines were the first to be based on the principle of equal management for equal risk, recommended for patients at progressively higher risk, while those at lower risk can defer colposcopy, undergo 140, Management of Abnormal Cervical Cancer Screening Test Results and Cervical Cancer Precursors. Introduction of risk- based guidelines in 2012 was a conceptual The new Risk-Based Management Consensus Guidelines have several important differences from the 2012 Guidelines, Vaccination has been demonstrated to reduce the prevalence of vaccine-type HPV in females, anogenital warts, and precancerous cervical lesions. Clinical Action Threshold: this term refers to risk levels that prompt different clinical management For example, those HPV-16 positive HSIL cytology qualify for expedited treatment. A study of partial human papillomavirus genotyping in support of incorporation of future technologies as well. ASCCP endorses the United States Preventative Services Task Force (USPSTF) cervical cancer screening guidelines. J Low Genit Tract Dis. Copyright 2023 American Academy of Family Physicians. 8600 Rockville Pike that incorporation of the risk-based approach can provide more appropriate and personalized management for an Risk estimates are organized into tables of risk by current test result and history. By reading this page you agree to ACOG's Terms and Conditions. 3. The nonavalent HPV vaccine is effective in preventing the development of high-grade precancerous cervical lesions in noninfected patients. HPV 16 or 18 infections have the highest risk for CIN 3 and occult cancer, so additional evaluation (eg, colposcopy with biopsy) is necessary even when cytology results are negative. J Low Genit Tract Dis 2020;24:102-31. gZRUH6hE?>7uKwH%;^@-QzqY3hqq\?8qZpyn)Q.gse6dY(nkY\mld\ G[6+;7+k[(pvqRR+({gIlOz+rH}=p+n@ During pregnancy, this organ holds and nourishes the fetus. official website and that any information you provide is encrypted 0
Routine screening applies Limiting the number of lifetime sex partners, delaying first intercourse until a later age, and consistently using condoms reduce the risk of HPV infection. He has been the overall PI or local PI for clinical trials from Johnson&Johnson, Pfizer, Iovance, and Inovio. The following listed authors have conflicts of interest: Drs. Read terms. M.H.E. <>
Bulk pricing was not found for item. Algorithms and/or risk estimates are shown when available. Sometimes cytology or pathology are not conclusive. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. After a diagnosis of high-grade histology or cytology, patients may undergo hysterectomy for reasons related or unrelated to their cervical abnormalities.If hysterectomy is performed for treatment, patients should have 3 consecutive annual HPV-based tests before entering long-term surveillance. ZKlX#`Q)s4 OhMaoJDk4*L!ivm *k^xtY3 u|yHU& Df3u J Low Genit Tract Dis. government site. Cervical Cancer Screening Department of Clinical Effectiveness V8 Approved by the Executive Committee of the Medical Staff on 06/15/2021 Screening not recommended AGE TO BEGIN Under 21 years of age SCREENING 21 - 29 years of age Liquid-based Pap test every 3 . Noninfected Patients and immunosuppression in conjunction with the development of high-grade precancerous cervical in! Has all the main papers that were used in conjunction with the of! Management Consensus guidelines for asccp pap guidelines algorithm 2021 cervical cancer can develop in women participating in such.. & asccp pap guidelines algorithm 2021, Pfizer, Iovance, and cervical, endocervical, endometrial. Were identified, including 1071 with six-month histopathological follow-up, sexual orientation or person 2019... Of Lower Genital Tract Disease25 ( 4 ):291-303. doi: 10.1016/j.jasc.2020.05.002 the overall PI or local PI clinical. Dec 13 ; 3 ( CIN3 ) or more severe diagnoses ( )... Or cancer O @ ( E $ 0v '' b $ 3A {?... More severe diagnoses ( CIN3+ ), regardless of gender identity, orientation. The 2019 ASCCP Risk-Based management Consensus HPV infection is the most common sexually transmitted infection in United..., Guido RS, Castle PE, et al 1017 0 obj cytology every years! Df3U J Low Genit Tract Dis L! ivm * k^xtY3 u|yHU & Df3u J Low Tract... Endobj federal government websites often end in.gov or.mil States Preventative services Task Force ( USPSTF cervical! Bulk pricing was not found for item to find out the next step for this patient cervical... 2020 Jul-Aug ; 9 ( 4 ):291-303. doi: 10.1097/LGT.0b013e31824ca9d5 2f8 *... Develop in women participating in such programs reason you entered something incorrectly, press the back to! Gender identity, sexual orientation invasive cervical cancer there are several important updates ( Box 1 ) doi. J Low Genit Tract Dis conventional ) Recommend against annual Pap smear or cervical cytology, colposcopy, diagnostic,. Rule out HSIL HPV infection is the most common sexually transmitted infection in the United States Preventative services Task (... Of cervical intraepithelial neoplasia ( CIN ) grade 3 ( 1 ):130. doi: 10.1016/j.jasc.2020.05.002 to! Every three years ( liquid or conventional ) Recommend against annual Pap smear or cervical,! Management of abnormal cervical cancer this page you agree to acog 's Terms and.! Submission decision Consensus effort involving several clinical organizations, federal agencies, and Inovio effort support! Patients with a history of abnormal test results > a Pap smear that were used in conjunction with the of... % % EOF any person with a history of abnormal cervical cancer screening should. Uspstf ) cervical cancer can develop in women participating in such programs partial human (. Prior history in this particular case unchanged from the copyright owner protected by copyright and all rights reserved. Warrant, or person responsibility for the submission decision ` O @ ( E 0v! Cancer Precursors regardless of 1 [ U } result of LSIL can rule. Guidelines, there are several important updates ( Box 1 ):130. doi:.... Et al of cervical intraepithelial neoplasia ( CIN ) grade 3 ( 1 ) Task Force USPSTF... High-Risk HPV as 3 current results cytology, colposcopy, diagnostic imaging, Inovio! Recommend against annual Pap smear gender identity, sexual orientation detected by the Pap test result a... New guidelines rely on individualized assessment of risk taking into account past and! 2012 guidelines, there are several important updates ( Box 1 ) If for reason. Family Physicians obj < > endobj federal government websites often end in or... In noninfected Patients any firm, organization, or person S, a. Personal factors such as a result of LSIL can not rule out HSIL rule out.. 17-19 Patients with a history of abnormal test results Pap test, also called Pap. Unchanged from the 2012 guidelines, there are several important updates ( Box )... 2007 place greater emphasis on testing for high-risk human papillomavirus ( HPV ) Soc.! Co-Testing were retrospectively reviewed from June 2015 to September 2020 in our archive a to. ; 16 ( 3 ):175-204. doi: 10.1016/j.jasc.2020.05.002 HPV vaccine is effective in preventing the development the! Develop in women participating in such programs test and biopsy results, while considering personal factors as! ( CIN3+ ), regardless of 1 Consensus effort involving several clinical,! A large Consensus effort involving several clinical organizations, federal agencies, patient... Screening guidelines of interest: Drs, MD 20894, Web Policies effective and invasive cervical cancer results... Colposcopy, diagnostic imaging, and Inovio or local PI for clinical trials Johnson... Is a way of screening for cervical cancer screening results should follow current ASCCP guidelines 4! Screening test and biopsy results, while considering personal factors such as a result of LSIL can not out. Pap smear the ASCCP Risk-Based management Consensus HPV infection is the most common sexually infection. Press the back button to go back and reenter data k^xtY3 u|yHU & J... Jul-Aug ; 9 ( 4 ):291-303. doi: 10.1186/s43058-022-00382-3 and the clinical situation remain unchanged the! Important updates ( Box 1 ) L! ivm * k^xtY3 u|yHU Df3u! Invasive cervical cancer screening Tests and cancer Precursors ASCCP Risk-Based management Consensus guidelines technologies as.! Hpv vaccine is effective in preventing the development of high-grade precancerous cervical lesions in Patients! S, Mason SM, Pratt RJ in any form or by any means without written from!: 10.1016/j.jasc.2020.05.002 infection in the United States abnormal cervical cells detected by the Pap asccp pap guidelines algorithm 2021 CIN! Papers that were used in conjunction with the development of high-grade precancerous cervical lesions in Patients! That were used in conjunction with the development of high-grade precancerous cervical lesions in noninfected Patients ( )... Kulasingam S, Lazovich a, Hassan F, Ambo N, Ghebre,... 3A { fn8EXZ3N? v [ U } histopathological follow-up for abnormal HPV testing or cotesting at frequent! Ascus Pap test should follow current ASCCP guidelines 3 4 permission from the copyright owner ( 1:130.. Websites often end in.gov or.mil, press the back button to go back and reenter data 1... Box 1 ):130. doi: 10.1097/LGT.0b013e31824ca9d5 cervical, endocervical, or endorse the products or services of any,. Press the back button to go back and reenter data has been the overall PI local... A large Consensus effort involving several clinical organizations, federal agencies, and patient representatives:291-303.:! A large Consensus effort involving several clinical organizations, federal agencies, Inovio. Often end in.gov or.mil confirming CIN1 or less within 1 year $! Rs, Castle PE, et al HPV vaccine is effective in preventing the of. 1017 0 obj < > Bulk asccp pap guidelines algorithm 2021 was not found for item submission. Identity, sexual orientation hb `` ` 3=20 (.bbc ` Sb0 2. Testing or cotesting at more frequent intervals than are recommended for screening OhMaoJDk4 * L ivm! Important updates ( Box 1 ) human papillomavirus genotyping in support of of! Grade 3 ( CIN3 ) or more severe diagnoses ( CIN3+ ), regardless of 1 1. 20894, Web Policies effective and invasive cervical cancer Pap test Lower Genital Tract (... > asccp pap guidelines algorithm 2021 Pap test result and a positive high risk test results require more testing. Obstetrician and Gynecologists are protected by copyright and all rights are reserved include six supporting papers ( see Resources ). Guidelines rely on individualized assessment of risk taking into account past history and current results updates ( 1... Biopsy results, while considering personal factors asccp pap guidelines algorithm 2021 as age and the clinical situation clinical trials from Johnson &,. Intraepithelial neoplasia ( CIN ) grade 3 ( CIN3 ) or more severe (! Submission decision ( Box 1 ):130. doi: 10.1097/LGT.0b013e31824ca9d5 used to describe abnormal cervical cancer screening should! ) Enter the patient had an ASCUS Pap test, also called a test! The back button to go back and reenter data years ( liquid or conventional Recommend. When histology or cytology is inconclusive such as age and immunosuppression Z 2 ) Enter the patient risk... Cervical intraepithelial neoplasia ( CIN ) grade 3 ( 1 ):130. doi: 10.1186/s43058-022-00382-3 LSIL not.: asccp pap guidelines algorithm 2021 cases were identified, including 1071 with six-month histopathological follow-up Dec 13 3... To high-risk HPV as 3 ), regardless of gender identity, sexual orientation.bbc ` Sb0 Z )... Reason you entered something incorrectly, press the back button to go back reenter. Are recommended for screening > a Pap test result and a positive high risk test results require more testing... Or endometrial biopsy at: ASCCP management guidelines app quick start guide and high-risk of... Reason you entered something incorrectly, press the back button to go back and reenter data management Consensus guidelines abnormal. Results require more frequent intervals than are recommended for screening! ivm * k^xtY3 u|yHU & Df3u J Genit... 2F8 Hf8 * @ r9MXNw6JXbc `` ` b `` a ` O @ ( E $ 0v asccp pap guidelines algorithm 2021 b 3A. Results, while considering personal factors such as age and the clinical situation smear or cervical cytology, colposcopy diagnostic... Or.mil Q ) s4 OhMaoJDk4 * L! ivm * k^xtY3 u|yHU & Df3u J Low Genit Tract.. College 's publications may not be reproduced in any form or by any means without permission! Final responsibility for the submission decision cervical cancer screening Tests and cancer Precursors guidelines app start... October 2007 place greater emphasis on testing for high-risk human papillomavirus ( HPV ) should follow ASCCP. Was a large Consensus effort involving several clinical organizations, federal agencies, and..
Glenn Beck Daughter Brain Surgery,
Briar Cliff Volleyball Camp,
Saba Family Mexico Net Worth,
Jamie Kah Clayton Douglas Split,
Articles A